Abbott Medical Optics

On September 16, Johnson & Johnson (NYSE: JNJ) announced plans to acquire Abbott Medical Optics for $4.325 billion in cash. Credit Suisse’s Vamil Divan maintains a Neutral rating on Johnson & Johnson, with a price target of $123. The Deal The deal is expected to close in Q1:17, and...